These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24863739)

  • 1. Changes in the prescription pattern of antipsychotics for schizophrenic outpatients after the implementation of a global budgeting program.
    Chiu HJ; Chou PH; Loh el-W; Lan TY; Wu BJ; Chang YY; Liu SZ; Lan TH
    J Chin Med Assoc; 2014 Jun; 77(6):325-32. PubMed ID: 24863739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
    Krzystanek M; Krupka-Matuszczyk I
    Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risperidone versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug prescription patterns in schizophrenia outpatients: analysis of data from a German health insurance fund.
    Weinbrenner S; Assion HJ; Stargardt T; Busse R; Juckel G; Gericke CA
    Pharmacopsychiatry; 2009 Mar; 42(2):66-71. PubMed ID: 19308881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
    Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
    Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prescription patterns of second-generation antipsychotics in schizophrenia outpatient setting.
    Julaeha J; Athiyah U; Hermansyah A
    J Basic Clin Physiol Pharmacol; 2019 Dec; 30(6):. PubMed ID: 31837257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. National changes in oral antipsychotic treatment for people with schizophrenia in primary care between 1998 and 2007 in the United Kingdom.
    Prah P; Petersen I; Nazareth I; Walters K; Osborn D
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):161-9. PubMed ID: 21858898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
    Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
    Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Non-Interventional Naturalistic Study of the Prescription Patterns of Antipsychotics in Patients with Schizophrenia from the Spanish Province of Tarragona.
    Gaviria AM; Franco JG; Aguado V; Rico G; Labad J; de Pablo J; Vilella E
    PLoS One; 2015; 10(10):e0139403. PubMed ID: 26427051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
    Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
    J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with high-dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture.
    Takahashi T; Otsubo T; Kunisawa S; Sasaki N; Imanaka Y
    Neuropsychopharmacol Rep; 2020 Sep; 40(3):224-231. PubMed ID: 32452649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient characteristics and prescription patterns of atypical antipsychotics among patients with schizophrenia.
    Ren XS; Kazis LE; Lee AF; Hamed A; Huang YH; Cunningham F; Miller DR
    J Clin Pharm Ther; 2002 Dec; 27(6):441-51. PubMed ID: 12472984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
    Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
    Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ziprasidone versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schwarz S; Bhoopathi PS; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006627. PubMed ID: 19821380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
    Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
    Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
    Sikirica V; Pliszka SR; Betts KA; Hodgkins P; Samuelson T; Xie J; Erder H; Dammerman R; Robertson B; Wu EQ
    J Manag Care Pharm; 2012; 18(9):676-89. PubMed ID: 23206211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the use and discontinuation of antipsychotics in clinical practice: an observational study.
    Taylor M; Shajahan P; Lawrie SM
    J Clin Psychiatry; 2008 Feb; 69(2):240-5. PubMed ID: 18363452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription preferences in antipsychotics and attitude towards the pharmaceutical industry in Belgium.
    Cleymans S; Morrens M; Bervoets C
    J Med Ethics; 2017 Jun; 43(6):359-363. PubMed ID: 27895084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.